DekaBank Deutsche Girozentrale
HZNP

DekaBank Deutsche Girozentrale’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101,655
Closed -$11.6M – 1554
2023
Q3 		$11.6M Sell
101,655
-49,177
-33% -$5.28M 0.03% 392
2023
Q2 		$15.4M Buy
150,832
+11,882
+9% +$1.25M 0.03% 358
2023
Q1 		$14.9M Sell
138,950
-106,678
-43% -$11.8M 0.04% 337
2022
Q4 		$27.3M Sell
245,628
-93,054
-27% -$7.73M 0.07% 254
2022
Q3 		$21.1M Buy
338,682
+106,495
+46% +$7.44M 0.06% 260
2022
Q2 		$18.7M Buy
232,187
+47,378
+26% +$4.49M 0.05% 279
2022
Q1 		$19.8M Sell
184,809
-6,476
-3% -$631K 0.05% 291
2021
Q4 		$20.3M Buy
191,285
+29,224
+18% +$3.19M 0.05% 283
2021
Q3 		$17.7M Buy
162,061
+4,318
+3% +$448K 0.05% 283
2021
Q2 		$14.7M Sell
157,743
-2,162
-1% -$199K 0.04% 310
2021
Q1 		$13.8M Sell
159,905
-9,302
-5% -$785K 0.05% 291
2020
Q4 		$11.8M Buy
169,207
+42,445
+33% +$3.15M 0.04% 302
2020
Q3 		$9.93M Buy
126,762
+94,600
+294% +$6.51M 0.04% 287
2020
Q2 		$1.78M Buy
32,162
+21,086
+190% +$902K 0.01% 526
2020
Q1 		$323K Sell
11,076
-1,623
-13% -$54.9K ﹤0.01% 826
2019
Q4 		$458K Sell
12,699
-75,700
-86% -$2.32M ﹤0.01% 849
2019
Q3 		$2.44M Sell
88,399
-69,205
-44% -$1.79M 0.02% 488
2019
Q2 		$3.79M Buy
157,604
+73,756
+88% +$1.87M 0.02% 478
2019
Q1 		$1.73M Buy
83,848
+31,848
+61% +$755K 0.01% 637
2018
Q4 		$993K Sell
52,000
-31,848
-38% -$624K 0.01% 684
2018
Q3 		$1.73M Sell
83,848
-9,726
-10% -$185K 0.01% 650
2018
Q2 		$1.53M Buy
93,574
+28,274
+43% +$431K 0.01% 647
2018
Q1 		$918K Sell
65,300
-11,300
-15% -$167K 0.01% 737
2017
Q4 		$911K Hold
76,600
– – 0.01% 708
2017
Q3 		$911K Hold
76,600
– – 0.01% 717
2017
Q2 		$905K Hold
76,600
– – 0.01% 717
2017
Q1 		$1.15M Sell
76,600
-6,500
-8% -$105K 0.01% 593
2016
Q4 		$1.35M Buy
83,100
+6,300
+8% +$114K 0.01% 495
2016
Q3 		$1.36M Buy
76,800
+40,000
+109% +$781K 0.02% 499
2016
Q2 		$616K Sell
36,800
-38,200
-51% -$618K 0.01% 639
2016
Q1 		$1.2M Sell
75,000
-6,000
-7% -$105K 0.01% 529
2015
Q4 		$1.81M Buy
81,000
+3,300
+4% +$64.2K 0.02% 475
2015
Q3 		$1.54M Buy
77,700
+5,400
+7% +$171K 0.02% 490
2015
Q2 		$2.51M Buy
72,300
+13,600
+23% +$415K 0.03% 413
2015
Q1 		$1.52M Sell
58,700
-5,000
-8% -$91.7K 0.02% 497
2014
Q4 		$809K Buy
63,700
+19,800
+45% +$248K 0.01% 598
2014
Q3 		$539K Buy
43,900
+1,800
+4% +$20.9K 0.01% 637
2014
Q2 		$666K Buy
42,100
+2,600
+7% +$37.1K 0.01% 563
2014
Q1 		$597K Buy
+39,500
New +$446K 0.01% 548

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

DekaBank Deutsche Girozentrale's HZNP Position: Q4 2023 in Review

DekaBank Deutsche Girozentrale sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 101,655 shares — an estimated $11.6M sold.

DekaBank Deutsche Girozentrale first reported a position in HZNP in Q1 2014 and held it in 39 quarters. The position peaked at $27.3M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 101,655 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.6M.
  • DekaBank Deutsche Girozentrale first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 39 quarters.
  • DekaBank Deutsche Girozentrale's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $27.3M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.